Roche Diagnostics R&D

Roche Diagnostics scientists are inventing, researching and developing next-generation medical tests and tools that help healthcare professionals diagnose disease and deliver patient care to improve, prolong and save lives.

As a healthcare pioneer, Roche Diagnostics pushes boundaries and challenges the status quo to redefine what’s possible. Our commitment to research and development means we can bring to the market integrated solutions in diagnostic testing, laboratory efficiency, healthcare digitalisation and decision support tools and software.

Roche is proud to research and develop diagnostic products for cancer,cardiac health,infectious diseases,women’s health,neurologyand diabetes management.

Around the world, more than 4,500 employees on more than 20 sites contribute to delivering products with increasingly precise information to help save lives, prevent or control the risk of infection and monitor treatment effectiveness.

The Roche Diagnostics R&D innovation engine includes activities in two divisions:

Roche Diagnostics Solutions

RDS is researching and developing comprehensive end-to-end diagnostic solutions to address the needs of medical labs and points of care, including diabetes care.

Roche Information Solutions

RIS is researching and developing digital solutions to help deliver medical value on integrated testing solutions, enabling confident healthcare decisions and improving care along the patient journey.

Roche Diagnostics is proud to bring to market healthcare products that are helping clinicians make decisions that allow people to live longer, healthier lives.

Roche presents major advances for its sequencing by expansion technology, including a new GUINNESS WORLD RECORD:tm:, at the ASHG conference 2025

Following its recent unveiling, SBX is already being recognized by early evaluators in the sequencing community for its combination of speed, flexibility, and longer reads, which significantly expands research possibilities.

For healthcare professionals

Learn about our innovative products and services that address the prevention, diagnosis, monitoring, screening, and treatment of diseases.

Visit diagnostics.roche.com

Diagnostic innovation starts here

See all stories

Roche’s diagnostic innovations are paving the way for a healthier future. Get to know our scientists and the stories behind our most impactful scientific breakthroughs.

Open atrium in modern office building, featuring multiple floors with glass walls, large white chandeliers, indoor plants, and people walking below.

Investing in the future of diagnostics: Roche’s new innovation center redefines research and development

In February 2026, Roche opened its new Diagnostics Innovation Center in Penzberg, Germany. Roche is establishing a modern and sustainable research and development center for approximately 1,000 employees.

February 12, 2026

Genomics, in a flash: A DNA sequencing world record

Roche is part of a team that has been officially recognized with a GUINNESS WORLD RECORDS™ title for the fastest DNA sequencing technique.

October 16, 2025

Series

Going with the flow: faster, more-flexible sequencing data analysis

Roche’s future DNA sequencing technology will offer a flexible workflow and the ability to analyze data as it's generated. This will mean greater control over sequencing data analysis and unprecedented efficiency.

September 04, 2025

Series

Women in science: Making automated mass spectrometry possible

Scientist Alice Schlichtiger is playing a part in changing mass spectrometry, which soon could be introduced into routine testing thanks to groundbreaking technological advances by Roche Diagnostics.

March 03, 2025

Series

Inventing SBX, a DNA sequencing breakthrough

Sequencing by expansion (SBX) technology has the potential to revolutionize the way DNA is sequenced, advancing scientific research for the future benefit of patients everywhere.

February 20, 2025

Series

‘Super beads’ invention automates powerful diagnostic technique

Roche’s innovation makes possible the ability to bring mass spectrometry to the routine laboratory, opening up its benefits to more clinicians and patients around the world.

December 18, 2024